Bladder cancer

L Dyrskjøt, DE Hansel, JA Efstathiou… - Nature Reviews …, 2023 - nature.com
Bladder cancer is a global health issue with sex differences in incidence and prognosis.
Bladder cancer has distinct molecular subtypes with multiple pathogenic pathways …

Managing metastatic melanoma in 2022: a clinical review

B Switzer, I Puzanov, JJ Skitzki, L Hamad… - JCO oncology …, 2022 - ascopubs.org
Cutaneous melanoma remains the most lethal of the primary cutaneous neoplasms, and
although the incidence of primary melanoma continues to rise, the mortality from metastatic …

Treatment of metastatic colorectal cancer: ASCO guideline

VK Morris, EB Kennedy, NN Baxter… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE To develop recommendations for treatment of patients with metastatic colorectal
cancer (mCRC). METHODS ASCO convened an Expert Panel to conduct a systematic …

Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆

LE Hendriks, KM Kerr, J Menis, TS Mok… - Annals of …, 2023 - annalsofoncology.org
Diagnosis of tumour type allows prognostication and triage for biomarker testing (see the
Supplementary Material Section 3 and Supplementary Figure S1, available at https://doi …

Management of salivary gland malignancy: ASCO guideline

JL Geiger, N Ismaila, B Beadle, JJ Caudell… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE To provide evidence-based recommendations for practicing physicians and
other healthcare providers on the management of salivary gland malignancy. METHODS …

Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer

XS Wang, YF Bai, V Verma, RL Yu… - JNCI: Journal of the …, 2023 - academic.oup.com
Background Adding radiotherapy (RT) to systemic therapy improves progression-free
survival (PFS) and overall survival (OS) in oligometastatic non-small cell lung cancer …

Stereotactic radiation for the comprehensive treatment of oligometastases (SABR-COMET): extended long-term outcomes

S Harrow, DA Palma, R Olson, S Gaede… - International Journal of …, 2022 - Elsevier
Purpose Long-term randomized data assessing the effect of ablative therapies in patients
with oligometastases are lacking. The Stereotactic Ablative Radiotherapy for the …

Safety and survival rates associated with ablative stereotactic radiotherapy for patients with oligometastatic cancer: a systematic review and meta-analysis

EJ Lehrer, R Singh, M Wang, VM Chinchilli… - JAMA …, 2021 - jamanetwork.com
Importance The oligometastatic paradigm postulates that patients with a limited number of
metastases can be treated with ablative local therapy to each site of disease with curative …

Stereotactic radiosurgery vs conventional radiotherapy for localized vertebral metastases of the spine: phase 3 results of NRG Oncology/RTOG 0631 randomized …

S Ryu, S Deshmukh, RD Timmerman, B Movsas… - JAMA …, 2023 - jamanetwork.com
Importance Spine metastasis can be treated with high-dose radiation therapy with advanced
delivery technology for long-term tumor and pain control. Objective To assess whether …

Addition of metastasis-directed therapy to intermittent hormone therapy for oligometastatic prostate cancer: the EXTEND phase 2 randomized clinical trial

C Tang, AD Sherry, C Haymaker, T Bathala… - JAMA …, 2023 - jamanetwork.com
Importance Despite evidence demonstrating an overall survival benefit with up-front
hormone therapy in addition to established synergy between hormone therapy and …